MSTN and Duchenne muscular dystrophy: Estrellas et al., using an injectable hydrogel delivery system made from hyaluronic acid and processed skeletal muscle extracellular matrix, delivered the myostatin inhibitor RK35 in a Duchene muscular dystrophy (DMD) mouse model (MDX) [21].